Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs

Written by

M2 Financial LLC, in conjunction with Capital-FORCE ETF Trust (“Capital-FORCE”), announced the results of the joint special meeting of shareholders of Innovator IBD^® Breakout Opportunities ETF (NYSE Arca: BOUT) and Innovator IBD^® 50 ETF (NYSE Arca: FFTY) (each a “Target Fund” and collectively, the “Target Funds”) held as of April 10, 2026.

The shareholders of each Target Fund have approved the reorganization of each Target Fund into a corresponding newly-created series of Capital-FORCE ETF Trust (each, an “Acquiring Fund”), as detailed in the table below (each, a “Reorganization” and collectively, the “Reorganizations”):

Target Funds	Acquiring Funds
Innovator IBD^® Breakout Opportunities ETF	CapForce IBD^® Breakout Opportunities ETF
Innovator IBD^® 50 ETF	CapForce IBD^® 50 ETF

As previously announced, the Reorganizations were approved by the Board of Trustees of the Innovator ETFs^® Trust at a meeting held on January 21, 2026. Subject to the satisfaction of certain customary closing conditions, the Reorganizations are expected to close by the end of April 2026. No assurance can be given as to the exact closing date of the Reorganizations. Upon the completion of the Reorganization, which is expected to be tax-free, the assets of each Target Fund will be transferred to, and the liabilities of each Target Fund will be assumed by, the respective Acquiring Fund. The shareholders of each Target Fund will receive shares of the respective Acquiring Fund with a value equal to the aggregate net asset value of the shares of the respective Target Fund held by them.

M2 Financial LLC is a limited liability company organized in the State of California and is an SEC registered investment adviser. Capital-FORCE (CapForce ETF) is an affiliate under common control. To learn more about Capital-FORCE, please call 800-324-3998 or visit www.capforceetf.com.

This press release is not intended to, and shall not, constitute an offer to purchase or sell shares of any Acquiring Fund. An investor should carefully consider the investment objectives, risks, charges and expenses of an Acquiring Fund before investing.